IN2012DN03632A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03632A IN2012DN03632A IN3632DEN2012A IN2012DN03632A IN 2012DN03632 A IN2012DN03632 A IN 2012DN03632A IN 3632DEN2012 A IN3632DEN2012 A IN 3632DEN2012A IN 2012DN03632 A IN2012DN03632 A IN 2012DN03632A
- Authority
- IN
- India
- Prior art keywords
- weight
- amount
- fos
- present
- inulin
- Prior art date
Links
- 229920001202 Inulin Polymers 0.000 abstract 2
- 150000004676 glycans Chemical class 0.000 abstract 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 2
- 229940029339 inulin Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 235000016709 nutrition Nutrition 0.000 abstract 2
- 229920001282 polysaccharide Polymers 0.000 abstract 2
- 239000005017 polysaccharide Substances 0.000 abstract 2
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 abstract 1
- 229920000189 Arabinogalactan Polymers 0.000 abstract 1
- 239000001904 Arabinogalactan Substances 0.000 abstract 1
- 229920002907 Guar gum Polymers 0.000 abstract 1
- 235000019312 arabinogalactan Nutrition 0.000 abstract 1
- 239000000665 guar gum Substances 0.000 abstract 1
- 229960002154 guar gum Drugs 0.000 abstract 1
- 235000010417 guar gum Nutrition 0.000 abstract 1
- 244000005709 gut microbiome Species 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Pediatric Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26049509P | 2009-11-12 | 2009-11-12 | |
| US26443009P | 2009-11-25 | 2009-11-25 | |
| US39480510P | 2010-10-20 | 2010-10-20 | |
| PCT/US2010/056321 WO2011060123A1 (en) | 2009-11-12 | 2010-11-11 | Nutritional composition for promoting gut microbiota balance and health |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN03632A true IN2012DN03632A (enrdf_load_html_response) | 2015-06-26 |
Family
ID=43567734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3632DEN2012 IN2012DN03632A (enrdf_load_html_response) | 2009-11-12 | 2010-11-11 |
Country Status (14)
Families Citing this family (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2012DN03632A (enrdf_load_html_response) * | 2009-11-12 | 2015-06-26 | Nestec Sa | |
| SG191393A1 (en) * | 2010-12-31 | 2013-08-30 | Abbott Lab | Neutral human milk oligosaccharides to promote growth of beneficial bacteria |
| CA2839524C (en) | 2011-06-20 | 2016-05-17 | H.J. Heinz Company | Probiotic compositions and methods |
| WO2012175639A1 (en) * | 2011-06-22 | 2012-12-27 | Universite De Rouen | Arabinogalactan proteins for use as an antiparasitic agent |
| FI126711B (fi) | 2011-10-12 | 2017-04-13 | Gut Guide Oy | Serotoniinivajeeseen liittyvän terveysriskin arvioiminen |
| WO2013057063A1 (en) | 2011-10-18 | 2013-04-25 | Nestec S.A. | Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease |
| TW201318566A (zh) * | 2011-11-01 | 2013-05-16 | Jimmy Lu | 膳食補充劑組合物及其用於調控血糖之方法 |
| WO2013130773A2 (en) | 2012-02-29 | 2013-09-06 | Ethicon Endo-Surgery, Inc. | Compositions of microbiota and methods related thereto |
| ITRM20120084A1 (it) | 2012-03-07 | 2013-09-08 | Aboca Spa Societa Agricola | Miscela prebiotica. |
| WO2014007606A1 (en) | 2012-07-05 | 2014-01-09 | N.V. Nutricia | Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour |
| AU2013338774B2 (en) * | 2012-11-01 | 2017-03-02 | Academisch Ziekenhuis Groningen | Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract |
| KR102617655B1 (ko) | 2012-11-23 | 2023-12-27 | 세레스 테라퓨틱스, 인코포레이티드 | 상승작용적 박테리아 조성물, 그리고 이의 제조 방법 및 용도 |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| US20150296851A1 (en) * | 2012-11-27 | 2015-10-22 | Shanghai Jiao Tong University | Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof |
| CA2899925A1 (en) | 2013-02-04 | 2014-08-07 | Seres Therapeutics, Inc. | Compositions and methods for inhibition of pathogenic bacterial growth |
| US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
| CA2906921A1 (en) | 2013-03-15 | 2014-09-18 | Seres Therapeutics, Inc. | Network-based microbial compositions and methods |
| CA2902248A1 (en) * | 2013-03-15 | 2014-09-25 | Microbiome Therapeutics, Llc | Activated soy pod fiber |
| GB201312713D0 (en) * | 2013-03-22 | 2013-08-28 | Weaver Connie M | Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption |
| GB201305708D0 (en) * | 2013-03-28 | 2013-05-15 | Clasado Inc | Novel use |
| CA2945184A1 (en) * | 2013-04-11 | 2014-10-16 | Bright Drinks Inc. | Compositions for prevention and/or treatment of gastrointestinal imbalances in digestive disorders |
| ITMI20131467A1 (it) * | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
| MX367109B (es) | 2013-11-25 | 2019-08-05 | Seres Therapeutics Inc | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. |
| EP3082431A4 (en) | 2013-12-16 | 2017-11-15 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| AU2014369772A1 (en) * | 2013-12-20 | 2016-05-19 | Nestec S.A. | Nutritional compositions for reducing intestinal pathogens |
| MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
| CN104187624B (zh) * | 2014-08-07 | 2016-06-08 | 逯明福 | 综合营养粉及其制备方法 |
| WO2016029113A1 (en) * | 2014-08-22 | 2016-02-25 | Abbott Laboratories | Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate |
| AU2014407509B2 (en) | 2014-09-30 | 2020-09-03 | Kimberly-Clark Worldwide, Inc. | Synergistic prebiotic composition |
| BR112017004118B1 (pt) | 2014-09-30 | 2022-04-12 | Kimberly-Clark Worldwide, Inc | Trama de papel crepado, produto de papel crepado de múltiplas camadas, e, método de fabricação de uma trama de papel crepado prebiótico |
| CN108064132A (zh) | 2014-10-31 | 2018-05-22 | 霍勒拜欧姆公司 | 与病症的微生物治疗和诊断有关的方法和组合物 |
| CN104432069A (zh) * | 2014-12-22 | 2015-03-25 | 威海百合生物技术股份有限公司 | 一种肠胃通畅片 |
| JP6338113B2 (ja) * | 2015-03-31 | 2018-06-06 | 株式会社東洋新薬 | 除脂肪体重の増加剤 |
| JP6861708B2 (ja) * | 2015-12-30 | 2021-04-21 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 除脂肪体重を測定するための方法 |
| CA3009427A1 (en) * | 2015-12-31 | 2017-07-06 | Nestec S.A. | Composition for improving mouthfeel |
| JP7016112B2 (ja) * | 2016-02-04 | 2022-02-04 | ユニベルシテイト ゲント | ヒトおよび動物の健康ための微生物コミュニティーの使用 |
| WO2017184565A1 (en) | 2016-04-20 | 2017-10-26 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for nucleic acid expression and protein secretion in bacteroides |
| MA45327A (fr) | 2016-05-13 | 2019-03-20 | Sofar Spa | Utilisation de probiotiques pour améliorer l'absorption des protéines |
| MA45288A (fr) | 2016-06-08 | 2019-04-17 | Sofar Spa | Nouvelle utilisation médicale de probiotiques |
| US20180030403A1 (en) | 2016-07-28 | 2018-02-01 | Bobban Subhadra | Devices, systems and methods for the production of humanized gut commensal microbiota |
| WO2018057914A1 (en) * | 2016-09-22 | 2018-03-29 | The University Of Chicago | Immune response modulation using live biotherapeutics, for conditions such as allergy desensitization |
| IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
| AU2017376780B2 (en) | 2016-12-15 | 2024-12-12 | Novome Biotechnologies, Inc. | Compositions and methods for modulating growth of a genetically modified gut bacterial cell |
| IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
| CN108245530A (zh) * | 2016-12-28 | 2018-07-06 | 兰州奇正生态健康品有限公司 | 一种具有润肠通便作用的组合物及其制备方法与用途 |
| ES2683014B1 (es) * | 2017-03-23 | 2019-01-16 | Cuetara S L | Galleta infantil sin azúcares añadidos |
| WO2018237149A1 (en) | 2017-06-21 | 2018-12-27 | Abbott Laboratories | Methods for increasing growth of beneficial bacteria in the gastrointestinal tract |
| MX2020001774A (es) | 2017-08-14 | 2020-09-09 | Seres Therapeutics Inc | Composiciones y métodos para tratar enfermedad colestásica. |
| CN111372596A (zh) | 2017-08-30 | 2020-07-03 | 潘德勒姆治疗公司 | 用于治疗微生物组相关病症的方法和组合物 |
| GB2566971B (en) * | 2017-09-28 | 2020-12-02 | Mjn Us Holdings Llc | Infant formula having decreased protein content |
| IT201700108033A1 (it) * | 2017-09-27 | 2019-03-27 | Neilos S R L | Composizione per il trattamento della costipazione |
| IT201700108039A1 (it) * | 2017-09-27 | 2019-03-27 | Neilos S R L | Composizione per il trattamento della costipazione |
| EP3466276A1 (en) | 2017-10-05 | 2019-04-10 | Pharmactive Biotech Products, S.L. | Dietary fiber composition for protecting bioactive compounds during the physiological digestion process |
| MX2020004495A (es) | 2017-10-30 | 2021-01-08 | Seres Therapeutics Inc | Composiciones y métodos para tratar la resistencia a los antibióticos. |
| CN111212575A (zh) * | 2017-10-31 | 2020-05-29 | 森永乳业株式会社 | 肌肉增量用组合物 |
| US11484547B2 (en) * | 2018-01-08 | 2022-11-01 | Performance Labs PTE. LTD. | Compositions and methods for cholesterol, glucose and microbiome control |
| WO2020018949A2 (en) | 2018-07-19 | 2020-01-23 | Pendulum Therapeutics, Inc. | Methods and compositions for microbial engraftment |
| US20200113858A1 (en) | 2018-10-15 | 2020-04-16 | Freedom Health, Llc | Human dietary supplement and method for treating digestive system and immune-related disorders |
| WO2020127630A1 (en) * | 2018-12-19 | 2020-06-25 | Cosucra Groupe Warcoing S.A. | Composition comprising chicory root and pea cell wall fiber for treating brachyspira infections |
| US11622974B2 (en) | 2019-01-18 | 2023-04-11 | C.P. Kelco U.S., Inc. | Prebiotic composition and its use |
| WO2020161522A1 (en) * | 2019-02-06 | 2020-08-13 | Thd S.P.A. | Fiber-based composition |
| FR3093427B1 (fr) * | 2019-03-05 | 2021-03-05 | Mativa Tech | Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose |
| US20220183586A1 (en) * | 2019-03-12 | 2022-06-16 | The Board Of Regents Of The University Of Texas System | Simultaneous blood glucose monitoring and gastric emptying scintigraphy |
| CN109820865A (zh) * | 2019-04-09 | 2019-05-31 | 福州大学 | 低聚木糖和部分水解的瓜尔豆胶复配组合物在预防肥胖及保健品中的应用 |
| JP7321503B2 (ja) * | 2019-05-21 | 2023-08-07 | フジ日本精糖株式会社 | イヌリンを含む筋肉量減少抑制又は骨密度減少抑制剤 |
| US20220248739A1 (en) | 2019-05-29 | 2022-08-11 | N.V. Nutricia | Non-digestible oligosaccharides for decreased colonic protein fermentation |
| CN114377160A (zh) * | 2019-07-09 | 2022-04-22 | 大连大学 | 一种落叶松阿拉伯半乳聚糖组合物的制备方法 |
| CA3148749A1 (en) * | 2019-08-30 | 2021-03-04 | Hem Pharma Inc. | Method for screening personalized intestinal environment-improving material and composition therefor |
| GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
| US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
| CN110679955A (zh) * | 2019-11-11 | 2020-01-14 | 成都高新区九州华昀医疗美容门诊部有限公司 | 可改善肠道功能的大鲵活性肽营养组合物 |
| PH12022552279A1 (en) * | 2020-02-27 | 2024-01-29 | Abbott Lab | Methods of improving bone health |
| CN115379846A (zh) * | 2020-04-24 | 2022-11-22 | 雀巢产品有限公司 | 包含纤维和桑树的组合物 |
| CN111440841A (zh) * | 2020-05-19 | 2020-07-24 | 爱礼康生物医药（苏州）有限公司 | 一种检测膳食纤维对人肠道菌活性影响的方法 |
| JP2023526287A (ja) * | 2020-05-20 | 2023-06-21 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | ビフィドバクテリウム・ロンガムの生存性及び代謝活性に対するイネ科及び／又はマメ科繊維の有益な効果 |
| AU2021281622A1 (en) * | 2020-05-29 | 2022-12-01 | Societe Des Produits Nestle Sa | Compositions and methods for digestive health in an animal |
| JP7688866B2 (ja) * | 2020-07-14 | 2025-06-05 | 物産フードサイエンス株式会社 | 筋肉量率を増加させる剤および方法、ならびに体脂肪率を減少させる剤および方法 |
| EP4231851A1 (en) * | 2020-10-21 | 2023-08-30 | Compagnie Gervais Danone | Acacia gum for iron induced microbial dysbiosis |
| JP2022072243A (ja) * | 2020-10-29 | 2022-05-17 | 帝人株式会社 | 腸内細菌叢改善用組成物及び腸内腐敗物質産生抑制用組成物 |
| CN112715669A (zh) * | 2020-11-24 | 2021-04-30 | 本溪木兰花乳业有限责任公司 | 一种改善便秘的牛奶制品及其制备方法 |
| WO2022122958A1 (en) | 2020-12-09 | 2022-06-16 | N.V. Nutricia | Fibre mixture for young children |
| EP4119135A1 (fr) * | 2021-07-13 | 2023-01-18 | Luxia Scientific | Methodes pour reequilibrer la flore intestinale chez les patients souffrant de la maladie de parkinson |
| CA3224787A1 (en) * | 2021-07-16 | 2023-01-19 | Ali Keshavarzian | Prebiotic composition and method of use to improve gastrointestinal health in patients with dysbiosis and leaky gut |
| CN113826892A (zh) * | 2021-09-17 | 2021-12-24 | 潍坊易北特健康食品有限公司 | 一种基于肠道微生物调控特定胆汁酸的组合物及制备方法 |
| JPWO2023054625A1 (enrdf_load_html_response) * | 2021-09-29 | 2023-04-06 | ||
| CN114224925A (zh) * | 2021-12-23 | 2022-03-25 | 广东格物生物科技有限公司 | 一种调节肠道健康的益生菌组合物及其制备方法 |
| ES2955633A1 (es) * | 2022-04-26 | 2023-12-04 | Servicio Andaluz De Salud | Composición para la rehabilitación intestinal |
| CN115025116B (zh) * | 2022-07-13 | 2023-11-21 | 纽湃腾（北京）医药科技有限公司 | 一种显著改善胃食管反流伴肠易激综合征的组合物及其应用 |
| WO2025106584A1 (en) * | 2023-11-14 | 2025-05-22 | Kate Farms, Inc. | Infant formula |
| GR1011003B (el) * | 2024-02-28 | 2025-07-22 | Cloudpharm Private Company, | Συμπληρωμα διατροφης για την αντιμετωπιση της απωλειας της οστικης πυκνοτητας (οστεοπενια) |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952314A (en) | 1994-04-01 | 1999-09-14 | Demichele; Stephen Joseph | Nutritional product for a person having ulcerative colitis |
| DE69506095T2 (de) | 1995-08-04 | 1999-06-24 | Naamloze Vennootschap Nutricia, Zoetermeer | Diätfasern enthaltende Nahrungszusammensetzung |
| DK1010374T3 (da) | 1998-12-15 | 2005-11-21 | Nestle Sa | Fiberblanding til enterale sammensætninger |
| AU3174601A (en) | 2000-03-01 | 2001-09-12 | Nestle Sa | Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| EP1175905A1 (en) | 2000-07-24 | 2002-01-30 | Societe Des Produits Nestle S.A. | Nutritional Composition |
| US6592863B2 (en) | 2000-08-22 | 2003-07-15 | Nestec S.A. | Nutritional composition |
| EP1243273A1 (en) | 2001-03-22 | 2002-09-25 | Societe Des Produits Nestle S.A. | Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters |
| GB0308104D0 (en) * | 2003-04-08 | 2003-05-14 | Novartis Nutrition Ag | Organic compounds |
| ITMI20040956A1 (it) | 2004-05-12 | 2004-08-12 | Curti Alessandro | Composizioni alimentari |
| EP1597978A1 (en) * | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
| US8252769B2 (en) * | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
| ES2334943T3 (es) * | 2005-10-05 | 2010-03-17 | Nestec S.A. | Uso de una formulacion nutritiva para fomentar la recuperacion del crecimiento. |
| ITMI20062031A1 (it) | 2006-10-23 | 2008-04-24 | Velleja Res Srl | Composizioni per la prevenzione del depauperamento della flora intestinale e del danno d'organo successivi a terapia antibiotica |
| IN2014DN03102A (enrdf_load_html_response) * | 2006-11-07 | 2015-07-10 | Procter & Gamble | |
| ITMI20071214A1 (it) * | 2007-06-15 | 2008-12-16 | S I I T Srl Servizio Internazi | Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale |
| DK2178385T4 (da) | 2007-07-18 | 2022-01-31 | Campina Nederland Holding Bv | Varmestabil næringsdrik og fremgangsmåde til fremstilling deraf |
| WO2009075564A1 (en) | 2007-12-10 | 2009-06-18 | N.V. Nutricia | Paediatric fibre mixture |
| JP5992654B2 (ja) | 2007-12-21 | 2016-09-14 | ニュートリー株式会社 | 整腸及び／又は便通改善のための組成物 |
| IN2012DN03632A (enrdf_load_html_response) * | 2009-11-12 | 2015-06-26 | Nestec Sa |
-
2010
- 2010-11-11 IN IN3632DEN2012 patent/IN2012DN03632A/en unknown
- 2010-11-11 PH PH1/2012/500687A patent/PH12012500687A1/en unknown
- 2010-11-11 MX MX2012004778A patent/MX336032B/es unknown
- 2010-11-11 CN CN2010800498229A patent/CN102595934A/zh active Pending
- 2010-11-11 AU AU2010319490A patent/AU2010319490B2/en active Active
- 2010-11-11 WO PCT/US2010/056321 patent/WO2011060123A1/en active Application Filing
- 2010-11-11 US US13/502,918 patent/US9192179B2/en active Active
- 2010-11-11 DK DK10779417.4T patent/DK2498626T3/en active
- 2010-11-11 CA CA2777941A patent/CA2777941C/en active Active
- 2010-11-11 CN CN201410364998.3A patent/CN104206946A/zh active Pending
- 2010-11-11 EP EP10779417.4A patent/EP2498626B1/en not_active Revoked
- 2010-11-11 JP JP2012538966A patent/JP6006117B2/ja active Active
- 2010-11-11 RU RU2012123959/13A patent/RU2012123959A/ru not_active Application Discontinuation
- 2010-11-11 ES ES10779417.4T patent/ES2545597T3/es active Active
- 2010-11-11 BR BR112012011294-5A patent/BR112012011294B1/pt active IP Right Grant
-
2015
- 2015-10-20 US US14/887,497 patent/US10015978B2/en active Active
-
2016
- 2016-02-15 JP JP2016025895A patent/JP6205003B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2777941A1 (en) | 2011-05-19 |
| BR112012011294A2 (pt) | 2015-09-15 |
| MX336032B (es) | 2016-01-07 |
| RU2012123959A (ru) | 2013-12-20 |
| US9192179B2 (en) | 2015-11-24 |
| JP2013510865A (ja) | 2013-03-28 |
| JP6006117B2 (ja) | 2016-10-12 |
| CN104206946A (zh) | 2014-12-17 |
| CA2777941C (en) | 2018-08-14 |
| EP2498626B1 (en) | 2015-06-17 |
| US10015978B2 (en) | 2018-07-10 |
| DK2498626T3 (en) | 2015-07-13 |
| PH12012500687A1 (en) | 2012-10-29 |
| US20160100617A1 (en) | 2016-04-14 |
| JP6205003B2 (ja) | 2017-09-27 |
| CN102595934A (zh) | 2012-07-18 |
| EP2498626A1 (en) | 2012-09-19 |
| ES2545597T3 (es) | 2015-09-14 |
| BR112012011294B1 (pt) | 2018-03-20 |
| JP2016166176A (ja) | 2016-09-15 |
| AU2010319490B2 (en) | 2015-03-19 |
| US20120269865A1 (en) | 2012-10-25 |
| AU2010319490A1 (en) | 2012-05-03 |
| HK1172516A1 (en) | 2013-04-26 |
| WO2011060123A1 (en) | 2011-05-19 |
| MX2012004778A (es) | 2012-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN03632A (enrdf_load_html_response) | ||
| NZ602249A (en) | Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders | |
| MY148405A (en) | Immunogenic composition | |
| WO2006110406A3 (en) | Compositions comprising probiotic and sweetener components | |
| MX2010005424A (es) | Proceso de recubrimiento particulado. | |
| WO2011056487A3 (en) | Stable thickener formulations | |
| MX2015006971A (es) | Composiciones alimenticias tipo barra. | |
| TNSN07360A1 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
| MY158319A (en) | Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid | |
| PH12012502159A1 (en) | Pharmaceutical compositions and methods of making same | |
| MX2019012939A (es) | Formulaciones que contienen linaclotida para administracion oral. | |
| MX351037B (es) | Composiciones de goma humectantes de la boca y productos que contienen las mismas. | |
| MX2011012297A (es) | Mejoramiento de la salud gastrointestinal, la inmunidad y el rendimiento mediante intervención dietética. | |
| PL2197456T3 (pl) | Kompozycje oftalmiczne na bazie polisacharydu z nasion tamaryndowca i kwasu hialuronowego | |
| NZ600094A (en) | Method of enhancing muscle protein synthesis | |
| MX2010000266A (es) | Un método para disminuir los síntomas del consumo de alcohol. | |
| NZ605147A (en) | Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations | |
| HRP20171861T1 (hr) | Dermatološki pripravak koji sadrži heparan sulfat | |
| WO2008073764A3 (en) | Substantially pure fluorescein | |
| MY175195A (en) | Nutritional compositions | |
| MX342947B (es) | Tratamiento de diabetes tipo 2. | |
| HRP20231090T1 (hr) | Pripravci i metode sinergističkog tretmana glikokaliksa | |
| IN2011KN05169A (enrdf_load_html_response) | ||
| MX353099B (es) | Metodo para producir particulas de polvo libre de poliamida impregnada con por lo menos un agente cosmetico o farmaceutico, y particulas de polvo libre de poliamida que tienen un contenido de por lo menos 25% en peso de por lo menos un agente cosmetico o farmaceutico diferente al agua. | |
| MX2011007288A (es) | Trozos en composicones alimenticias gelatinosas. |